Literature DB >> 25972691

Synchronous collision neuroendocrine tumor and rectal adenocarcinoma: a case report.

Jie-Gao Zhu1, Zhong-Tao Zhang2, Guo-Cong Wu1, Wei Han1, Kang-Li Wang1.   

Abstract

Collision tumors are thought to arise from the accidental meeting of two independent tumors. Adenocarcinoma is the most common malignant rectal tumor, while neuroendocrine tumor (NET) is relatively rare. Due to the endoscopy and reporting, the overall incidence of NETs was increasing recently but still less than 1 per 100,000. This means that a combination of an adenocarcinoma and NET is a very rare finding and an actual collision of these tumors even more so. We report here a highly unusual case of a 64-year-old woman who had collision tumors composed of a primary rectal adenocarcinoma and NET showing a "side by side" pattern. Resection margins are free of both the tumors. The postoperative course was uneventful. The patient underwent a protocol CT scan at 3 months after surgery, which did not show any recurrence. Both the malignant adenocarcinoma and the NET would make a great influence in the rest lifetime and a follow up will be continued, although the CT did not show any recurrence until now. To the best of our knowledge, this is the first reported case of such an occurrence.

Entities:  

Keywords:  Adenocarcinoma; Collision tumor; Neuroendocrine tumor; Rectum

Year:  2015        PMID: 25972691      PMCID: PMC4425797          DOI: 10.1007/s12262-015-1256-1

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  7 in total

Review 1.  Gastrointestinal carcinoid tumors and second primary malignancies.

Authors:  N Habal; C Sims; A J Bilchik
Journal:  J Surg Oncol       Date:  2000-12       Impact factor: 3.454

2.  Risk of second cancers in patients with colorectal carcinoids.

Authors:  David S Tichansky; Burt Cagir; Edward Borrazzo; Allan Topham; Juan Palazzo; Eric J Weaver; Andrea Lange; Robert D Fry
Journal:  Dis Colon Rectum       Date:  2002-01       Impact factor: 4.585

3.  Colorectal tumors: the histology report.

Authors:  Giovanni Lanza; Luca Messerini; Roberta Gafà; Mauro Risio
Journal:  Dig Liver Dis       Date:  2011-03       Impact factor: 4.088

Review 4.  Colonic and rectal NET's.

Authors:  Dalvinder Mandair; Martyn E Caplin
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-12       Impact factor: 3.043

Review 5.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

6.  Collision tumor of the thyroid: a case report of metastatic liposarcoma plus papillary thyroid carcinoma.

Authors:  Margaret Brandwein-Gensler; Mark Urken; Beverly Wang
Journal:  Head Neck       Date:  2004-07       Impact factor: 3.147

7.  A 5-decade analysis of 13,715 carcinoid tumors.

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

  7 in total
  3 in total

1.  Rapamycin Treatment for Benign Multicystic Peritoneal Mesothelioma: A Rare Disease with a Difficult Management.

Authors:  Giovanni Stallone; Barbara Infante; Luigi Cormio; Luca Macarini; Giuseppe Grandaliano
Journal:  Am J Case Rep       Date:  2017-06-05

2.  Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality?

Authors:  Rafael Parra-Medina; Paula Moreno-Lucero; Julian Jimenez-Moreno; Alejandra María Parra-Morales; Alfredo Romero-Rojas
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

Review 3.  A rare case of metachronous neuroendocrine tumor after a colorectal adenocarcinoma: qualitative critical review of synchronous and metachronous gastrointestinal NET.

Authors:  Francesco Lancellotti; Luigi Solinas; Davide Telesco; Andrea Sagnotta; Augusto Belardi; Giuseppina Balsamo; Stefano Mancini
Journal:  Clin J Gastroenterol       Date:  2020-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.